Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.

MLA

Breese, Erin H., et al. “Use of CD19-Directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.” Journal of Pediatric Hematology/Oncology, vol. 43, no. 4, May 2021, pp. 152–54. EBSCOhost, https://doi.org/10.1097/MPH.0000000000001857.

APA

Breese, E. H., Krupski, C., Nelson, A. S., Perentesis, J. P., & Phillips, C. L. (2021). Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology, 43(4), 152–154. https://doi.org/10.1097/MPH.0000000000001857

Chicago

Breese, Erin H, Christa Krupski, Adam S Nelson, John P Perentesis, and Christine L Phillips. 2021. “Use of CD19-Directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.” Journal of Pediatric Hematology/Oncology 43 (4): 152–54. doi:10.1097/MPH.0000000000001857.